5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 15.61▲ | 15.76▼ | 15.86▼ | 15.77▼ | 14.02▲ |
MA10 | 15.66▼ | 15.92▼ | 16.02▼ | 15.16▲ | 11.68▲ |
MA20 | 15.71▼ | 16.04▼ | 15.95▼ | 13.27▲ | 11.34▲ |
MA50 | 15.91▼ | 15.88▼ | 15.76▼ | 10.99▲ | 13.87▲ |
MA100 | 16.05▼ | 15.67▼ | 14.36▲ | 11.16▲ | 16.92▼ |
MA200 | 15.99▼ | 14.16▲ | 12.18▲ | 12.96▲ | 18.62▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.070▼ | -0.078▼ | 0.224▲ | 0.949▲ |
RSI | 39.178▼ | 35.809▼ | 44.374▼ | 72.211▲ | 62.005▲ |
STOCH | 19.136▼ | 11.295▼ | 19.551▼ | 87.166▲ | 74.057 |
WILL %R | -52.273 | -87.195▼ | -87.195▼ | -16.939▲ | -9.301▲ |
CCI | -52.688 | -159.198▼ | -199.825▼ | 70.431 | 161.613▲ |
Monday, August 04, 2025 02:47 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) posted GAAP revenue of $38.0 million in Q2 2025 and far above analyst estimates. GAAP net loss per share was $(0.83) for Q2 2025, a narrower GAAP loss than the ...
|
Thursday, July 03, 2025 12:59 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) and AstraZeneca (NYSE:AZN) enter into a clinical trial collaboration to evaluate the safety ...
|
Wednesday, May 28, 2025 03:03 AM
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)'s primary focus is on two key drug candidates: revumenib for acute leukemias and axatilimab for chronic graft-versus-host disease (cGVHD).
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/08/25 | 16.305 | 16.37 | 15.55 | 15.655 | 1,274,383 |
22/08/25 | 15.97 | 16.38 | 15.81 | 16.24 | 1,470,301 |
21/08/25 | 15.63 | 16.0399 | 15.4318 | 15.84 | 1,229,241 |
20/08/25 | 15.43 | 15.89 | 15.37 | 15.74 | 2,168,370 |
19/08/25 | 15.87 | 16.3299 | 15.36 | 15.395 | 1,970,804 |
18/08/25 | 15.64 | 16.03 | 15.57 | 15.87 | 1,859,405 |
15/08/25 | 14.80 | 15.98 | 14.80 | 15.74 | 5,089,280 |
14/08/25 | 13.385 | 14.81 | 13.26 | 14.73 | 3,022,789 |
13/08/25 | 13.17 | 13.60 | 13.02 | 13.45 | 2,343,745 |
12/08/25 | 12.67 | 13.29 | 12.62 | 12.97 | 2,334,444 |
|
|
||||
|
|
||||
|
|